79196143 - ALG PHARMA

Information

• Trademark
• 79196143

• Source

• Serial Number

  79196143

• Registration Number

  5445428

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 07, 2016
  7 years ago

• Registration Date

  April 17, 2018
  6 years ago

• Transaction Date

  April 17, 2023
  a year ago

• Status Date

  April 17, 2018
  6 years ago

• Published for Opposition Date

  January 30, 2018
  6 years ago

• Location Date

  June 14, 2021
  2 years ago

• Status Code

  700

• Current Location

  TMO LAW OFFICE 115

  Employee Name

  LEIPZIG, MARC J

• Attorney Docket Number

  CLV 0438 US

  Attorney Name

  Jeannine A Rittenhouse

  Law Office Assigned Location Code

  M60

• Owners

  • AMADEITE

Case File Statements

• DM0000: The mark consists of the wording "ALG PHARMA" in teal, appearing above three curved bands; a teal band is just above a light blue band, with a green hand appearing across the middle of the two.
• B00001: In the Statement, classes 1, 5, and 42 have been corrected per the Fnote dated 9/21/2018.
• GS0051: Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorder, of urinary and sexual disorder, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; sanitary preparations for medical purposes; dietetic foods adapted for medical purposes for human use, namely, cereals and cereal-based foods made with grains and flours in the nature of breads, pastas, tortillas, sweet biscuits, savoury biscuits, cakes, doughs, crispbread and breakfast cereals, vegetables and vegetable-based foods made with texturized vegetable protein, leaf proteins, soya, fungi, vegetable juices, algae, fruit juices, nuts and seeds and nut-based foods, fish, mollusks and their eggs, crustaceans and their eggs, processed, dried, salted, smoked and canned fish, meat and meat-based foods in the nature of processed meat, eggs, milk and milk-based foods and beverages in the nature of creams, yoghurts, cheeses, milk-based cream desserts and ice creams, sugars and syrups being confectionery, desserts, jams jellies, preserves, beverages in the nature of teas, coffees, cordials, soft drinks, fruit flavoured drinks, herbs, spices; food for babies; food supplements for humans; disinfectants; preparations for destroying vermin; fungicides, [ herbicides, ] parasiticides * ; all the aforesaid goods pertaining to the pharmaceutical sector * ; plant extracts for pharmaceutical use; medicinal plant extracts; diagnostic agents for medical purposes; living cells for medical use; stem cells for medical use; enzymes for medical use; bacteriological preparations for medical use; plant preparations being plan extracts for medical use; bacteriological preparations for medical use; biochemical preparations for medical purposes, namely, for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorder, of urinary and sexual disorder, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; biological preparations for medical use, namely, for the for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorders, of urinary and sexual disorders, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; biotechnological preparations for medical use, namely, for the for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorder, of urinary and sexual disorder, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; alginates for pharmaceutical use; iodine for pharmaceutical use * ; all the aforesaid goods being algae-based and none of these goods intended for use in connection with the treatment of allergies, asthma, rhinitis, anaphylactic reactions and other respiratory diseases *
• B00002: In the Statement, class 5 has been corrected per the Fnote dated 6/8/2021.
• CC0000: The color(s) teal, light blue and green is/are claimed as a feature of the mark.
• GS0011: Seaweeds for use as fertilizers; algae for use as fertilizers; calcium-based algae nutrient supplements for use in aquariums; algae extracts for the manufacture of pharmaceutical products, namely, in the nature of dietary food supplements, pharmaceuticals and veterinary products; nutritive additive to enhance the biological activity of plants for purposes of fertilization and bioremediation of pollutants; seaweed and seaweed extracts for preventing infections in plants; chemical preparations of trace elements for preventing infections in plants; plant growth regulating preparations; cultures of microorganisms other than for medical and veterinary use; biological tissue cultures other than for medical or veterinary [ purposes ] * use * ; biological preparations for use in cell cultures other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary [ purposes ] * use * ; preparations of microorganisms other than for medical or veterinary use; chemical reagents other than for medical or veterinary use; chemical preparations for scientific use other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use * ; all the aforesaid goods being algae-based and none of these goods intended for use in connection with the treatment of allergies, asthma, rhinitis, anaphylactic reactions and other respiratory diseases *
• D10000: "PHARMA"
• GS0421: Chemical analysis ; scientific analyses, namely, scientific research and scientific laboratory services ; engineering services in the fields of science and technology provided by engineers; scientific and technical research in the fields of human health, human nutrition, animal welfare, animal health, animal nutrition, horticulture and agriculture, algae-based products for food industry and human health; medical research; development of pharmaceutical preparations and medicines; research in the field of pharmaceuticals; research and development in the field of pharmaceuticals; conducting clinical trials for pharmaceutical products; research and development of new products for others in the field of pharmaceuticals; scientific research and development; research and development of vaccines and medicines; medical research laboratory services; conducting scientific feasibility studies * ; all the aforesaid services in connection with the study of algae and none of these services intended for use in connection with the treatment of allergies, asthma, rhinitis, anaphylactic reactions and other respiratory diseases *

Case File Event Statements

• 4/17/2023 - a year ago

  38 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 6/25/2022 - a year ago

  37 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 6/25/2022 - a year ago

  36 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 6/14/2021 - 2 years ago

  35 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.

• 4/19/2021 - 3 years ago

  34 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.

• 9/21/2018 - 5 years ago

  33 - LIMITATION FROM THE IB EXAMINED AND ENTERED Type: LIME

• 8/31/2018 - 5 years ago

  32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 8/17/2018 - 5 years ago

  31 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG

• 8/4/2018 - 5 years ago

  30 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 8/4/2018 - 5 years ago

  29 - FINAL DISPOSITION PROCESSED Type: FIMP

• 7/17/2018 - 5 years ago

  28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 4/17/2018 - 6 years ago

  27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/30/2018 - 6 years ago

  26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/30/2018 - 6 years ago

  25 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/26/2018 - 6 years ago

  24 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 1/10/2018 - 6 years ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/10/2018 - 6 years ago

  22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 1/10/2018 - 6 years ago

  21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/21/2017 - 6 years ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/21/2017 - 6 years ago

  19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/21/2017 - 6 years ago

  18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 12/21/2017 - 6 years ago

  17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 12/21/2017 - 6 years ago

  16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 7/6/2017 - 6 years ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 7/6/2017 - 6 years ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 7/6/2017 - 6 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 6/8/2017 - 6 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/7/2017 - 6 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/7/2017 - 6 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/24/2016 - 7 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 12/7/2016 - 7 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 12/7/2016 - 7 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 11/24/2016 - 7 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 11/23/2016 - 7 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/22/2016 - 7 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 11/18/2016 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/18/2016 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/17/2016 - 7 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR